Pulmonary vascular improvement in severe COVID-19 patients treated with tocilizumab

L Salvati, M Occhipinti, L Gori, L Ciani, A Mazzoni… - Immunology …, 2020 - Elsevier
As of October 2020 management of Coronavirus disease 2019 (COVID-19) is based on
supportive care and off-label or compassionate-use therapies. On March 2020 tocilizumab …
被引用次数：20 相关文章
[HTML] nih.gov

[HTML][HTML] Pulmonary vascular improvement in severe COVID-19 patients treated with tocilizumab

L Salvati, M Occhipinti, L Gori, L Ciani… - Immunology …, 2020 - ncbi.nlm.nih.gov
As of October 2020 management of Coronavirus disease 2019 (COVID-19) is based on
supportive care and off-label or compassionate-use therapies. On March 2020 tocilizumab …

Pulmonary vascular improvement in severe COVID-19 patients treated with tocilizumab.

L Salvati, M Occhipinti, L Gori, L Ciani… - Immunology …, 2020 - europepmc.org
As of October 2020 management of Coronavirus disease 2019 (COVID-19) is based on
supportive care and off-label or compassionate-use therapies. On March 2020 tocilizumab …

Pulmonary vascular improvement in severe COVID-19 patients treated with tocilizumab

L Salvati, M Occhipinti, L Gori, L Ciani… - IMMUNOLOGY …, 2020 - flore.unifi.it
As of October 2020 management of Coronavirus disease 2019 (COVID-19) is based on
supportive care and off-label or compassionate-use therapies. On March 2020 tocilizumab …

Pulmonary vascular improvement in severe COVID-19 patients treated with tocilizumab

L Salvati, M Occhipinti, L Gori, L Ciani… - Immunology …, 2020 - pubmed.ncbi.nlm.nih.gov
As of October 2020 management of Coronavirus disease 2019 (COVID-19) is based on
supportive care and off-label or compassionate-use therapies. On March 2020 tocilizumab …

Pulmonary vascular improvement in severe COVID-19 patients treated with tocilizumab.

L Salvati, M Occhipinti, L Gori, L Ciani, A Mazzoni… - 2020 - cabidigitallibrary.org
As of October 2020 management of Coronavirus disease 2019 (COVID-19) is based on
supportive care and off-label or compassionate-use therapies. On March 2020 tocilizumab …

Pulmonary vascular improvement in severe COVID-19 patients treated with tocilizumab.

L Salvati, M Occhipinti, L Gori, L Ciani… - Immunology …, 2020 - europepmc.org
As of October 2020 management of Coronavirus disease 2019 (COVID-19) is based on
supportive care and off-label or compassionate-use therapies. On March 2020 tocilizumab …